| 摘要 |
This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergi c dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infa nt death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative i s administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above.
|
